The examine confirmed no unusual dangers, which indicated that it could be safely and securely administered in just a clinical research context. Later on, Dr. Charles Grob asked for authorization to more examine the compound with most cancers people, but was denied with the FDA two times.In 2011, the first concluded medical demo analyzing the oppor